130 related articles for article (PubMed ID: 35400195)
1. Use of colistin with rifampicin, trimethoprim-sulfamethoxazole and teicoplanin in
Yesil C; Yalcin AN; Ogunc D; Ongut G; Ozhak B; Colak D; Er H; Sarıtas ZE
Future Microbiol; 2022 Jun; 17():665-671. PubMed ID: 35400195
[No Abstract] [Full Text] [Related]
2. Trimethoprim-sulfamethoxazole vs. colistin or ampicillin-sulbactam for the treatment of carbapenem-resistant Acinetobacter baumannii: A retrospective matched cohort study.
Raz-Pasteur A; Liron Y; Amir-Ronen R; Abdelgani S; Ohanyan A; Geffen Y; Paul M
J Glob Antimicrob Resist; 2019 Jun; 17():168-172. PubMed ID: 30557685
[TBL] [Abstract][Full Text] [Related]
3. In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii.
Bae S; Kim MC; Park SJ; Kim HS; Sung H; Kim MN; Kim SH; Lee SO; Choi SH; Woo JH; Kim YS; Chong YP
Antimicrob Agents Chemother; 2016 Nov; 60(11):6774-6779. PubMed ID: 27600048
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model.
Montero A; Ariza J; Corbella X; Doménech A; Cabellos C; Ayats J; Tubau F; Borraz C; Gudiol F
J Antimicrob Chemother; 2004 Dec; 54(6):1085-91. PubMed ID: 15546972
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model.
Song JY; Cheong HJ; Lee J; Sung AK; Kim WJ
Int J Antimicrob Agents; 2009 Jan; 33(1):33-9. PubMed ID: 18835761
[TBL] [Abstract][Full Text] [Related]
6. In Vitro Bactericidal Activity of Trimethoprim-Sulfamethoxazole Alone and in Combination with Colistin against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates.
Nepka M; Perivolioti E; Kraniotaki E; Politi L; Tsakris A; Pournaras S
Antimicrob Agents Chemother; 2016 Nov; 60(11):6903-6906. PubMed ID: 27550356
[TBL] [Abstract][Full Text] [Related]
7. Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii.
Motaouakkil S; Charra B; Hachimi A; Nejmi H; Benslama A; Elmdaghri N; Belabbes H; Benbachir M
J Infect; 2006 Oct; 53(4):274-8. PubMed ID: 16442632
[TBL] [Abstract][Full Text] [Related]
8. Colistin offers prolonged survival in experimental infection by multidrug-resistant Acinetobacter baumannii: the significance of co-administration of rifampicin.
Pantopoulou A; Giamarellos-Bourboulis EJ; Raftogannis M; Tsaganos T; Dontas I; Koutoukas P; Baziaka F; Giamarellou H; Perrea D
Int J Antimicrob Agents; 2007 Jan; 29(1):51-5. PubMed ID: 17189095
[TBL] [Abstract][Full Text] [Related]
9. Colistin-glycopeptide combinations against multidrug-resistant
Sanderink D; Cassisa V; Chenouard R; Mahieu R; Kempf M; Dubée V; Eveillard M
Future Microbiol; 2019 May; 14():581-586. PubMed ID: 31172805
[No Abstract] [Full Text] [Related]
10. Colistin enhances therapeutic efficacy of daptomycin or teicoplanin in a murine model of multiresistant Acinetobacter baumannii sepsis.
Cirioni O; Simonetti O; Pierpaoli E; Barucca A; Ghiselli R; Orlando F; Pelloni M; Trombettoni MM; Guerrieri M; Offidani A; Giacometti A; Provinciali M
Diagn Microbiol Infect Dis; 2016 Dec; 86(4):392-398. PubMed ID: 27712928
[TBL] [Abstract][Full Text] [Related]
11. Trimethoprim/sulfamethoxazole for Acinetobacter spp.: A review of current microbiological and clinical evidence.
Falagas ME; Vardakas KZ; Roussos NS
Int J Antimicrob Agents; 2015 Sep; 46(3):231-41. PubMed ID: 26070662
[TBL] [Abstract][Full Text] [Related]
12. In vivo activity of co-trimoxazole combined with colistin against Acinetobacter baumannii producing OXA-23 in a Galleria mellonella model.
Khalil MAF; Moawad SS; Hefzy EM
J Med Microbiol; 2019 Jan; 68(1):52-59. PubMed ID: 30422109
[TBL] [Abstract][Full Text] [Related]
13. Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial.
Durante-Mangoni E; Signoriello G; Andini R; Mattei A; De Cristoforo M; Murino P; Bassetti M; Malacarne P; Petrosillo N; Galdieri N; Mocavero P; Corcione A; Viscoli C; Zarrilli R; Gallo C; Utili R
Clin Infect Dis; 2013 Aug; 57(3):349-58. PubMed ID: 23616495
[TBL] [Abstract][Full Text] [Related]
14. In vitro antimicrobial synergy of colistin with rifampicin and carbapenems against colistin-resistant Acinetobacter baumannii clinical isolates.
Hong DJ; Kim JO; Lee H; Yoon EJ; Jeong SH; Yong D; Lee K
Diagn Microbiol Infect Dis; 2016 Oct; 86(2):184-9. PubMed ID: 27475960
[TBL] [Abstract][Full Text] [Related]
15. Colistin and rifampicin combination in the treatment of ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
Song JY; Lee J; Heo JY; Noh JY; Kim WJ; Cheong HJ; Hwang IS
Int J Antimicrob Agents; 2008 Sep; 32(3):281-4. PubMed ID: 18650070
[No Abstract] [Full Text] [Related]
16. Efficacy of rifampin and its combinations with imipenem, sulbactam, and colistin in experimental models of infection caused by imipenem-resistant Acinetobacter baumannii.
Pachón-Ibáñez ME; Docobo-Pérez F; López-Rojas R; Domínguez-Herrera J; Jiménez-Mejias ME; García-Curiel A; Pichardo C; Jiménez L; Pachón J
Antimicrob Agents Chemother; 2010 Mar; 54(3):1165-72. PubMed ID: 20047914
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of colistin versus beta-lactams, aminoglycosides, and rifampin as monotherapy in a mouse model of pneumonia caused by multiresistant Acinetobacter baumannii.
Montero A; Ariza J; Corbella X; Doménech A; Cabellos C; Ayats J; Tubau F; Ardanuy C; Gudiol F
Antimicrob Agents Chemother; 2002 Jun; 46(6):1946-52. PubMed ID: 12019113
[TBL] [Abstract][Full Text] [Related]
18. In vitro synergistic activity of colistin and teicoplanin combination against multidrug-resistant Acinetobacter spp.
Rady OMSM; El-Attar L; Amine A
J Antibiot (Tokyo); 2022 Mar; 75(3):181-184. PubMed ID: 35091666
[TBL] [Abstract][Full Text] [Related]
19. In vivo efficacy of glycopeptide-colistin combination therapies in a Galleria mellonella model of Acinetobacter baumannii infection.
Hornsey M; Wareham DW
Antimicrob Agents Chemother; 2011 Jul; 55(7):3534-7. PubMed ID: 21502628
[TBL] [Abstract][Full Text] [Related]
20. Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies.
Cai Y; Chai D; Wang R; Liang B; Bai N
J Antimicrob Chemother; 2012 Jul; 67(7):1607-15. PubMed ID: 22441575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
